期刊文献+

维持性血液透析患者心脏瓣膜钙化及其危险因素分析 被引量:3

CARDIAC VALVE CALCIFICATION IN MAITENANCE HAEMODIALYSIS PATIENTS AND ANALYSIS FOR RISK FACTORS
原文传递
导出
摘要 目的观察终末期肾病维持性血液透析(MHD)患者心脏瓣膜钙化(VC)的发病情况并对相关危险因素进行分析。方法对稳定透析6个月以上的MHD患者96例使用HP-550型彩色超声诊断仪进行心脏VC情况检测,将患者分为VC组与无VC组,比较二组患者的年龄、性别、透析时间、吸烟、血压、糖尿病肾病、SGA评分、血清白蛋白(Alb)、前白蛋白(pA)、血脂、血钙、血磷、钙磷乘积、全段甲状旁腺激素(iPTH)以及心脏室间隔厚度(IVS)、左室舒张期内径(LVID)、射血分数(EF)和左室肥厚(LVH)的发生率等指标。结果 96例MHD患者中34例(35.42%)发生VC。VC组透析时间显著长于无VC组,中重度营养不良的发生率、钙磷乘积明显增高(>4.43 mmol2/L2)者、CRP、室间隔厚度(IVS)、左室舒张期内经(LVID)、左室肥厚(LVH)发生率等均显著高于无VC组,此外,血清白蛋白(Alb)、前白蛋白(PA)、EF显著低于无VC组,吸烟、高血压、糖尿病、血脂异常、血钙、血磷、iPTH等指标二组比较差异无统计学意义,但是二组患者的iPTH显著高于正常人群。结论钙磷乘积增高,甲状旁腺功能亢进、炎症、营养不良等均为MHD患者VC发生的危险因素。VC发生后,MHD患者更容易出现心脏结构和功能改变。 Objective To observe the cardiac valve calcification(VC) in maintenance haemodialysis (MHD) patients and to analyse the related risk factors. Methods we studied 96 patients on MHD for more than 6 months. The color doppler ultrasonography was carried out to detect the cardiacVC and ventricular geometry. The patients were divided into two groups:VC group and no VC group. The SGA score, plasma albumin,pre - albumin, lipid profile, calcium, phosphate and calcium - phosphorus product (Ca P) ,parathormone,C responsive protein(CRP) were determined. Results 34 patients(35.42%) presented with VC Compared with patients with no VC, Patients with VC were'older, had longer time on haemodialysis, higher Ca × P product and CRP, higher proportion of patients with moderate to severe malnutrition, lower serum albumin and prealbumin,poor ventricular geometry. Conclusion Aging,Time on haemodialysis, high Ca × P product,inflammation and malnutrition are associated with cardiac VC.
出处 《中国煤炭工业医学杂志》 2011年第6期789-791,共3页 Chinese Journal of Coal Industry Medicine
基金 河北省科技厅研究与发展计划项目(072761247)
关键词 维持性血液透析 终末期肾病 心脏瓣膜钙化 maintenance haemodialysis endstage renal disease cardiac valve calcification
  • 相关文献

参考文献9

  • 1Yee - Moon WangA, Siri - Yee Ho S, Wang M, et al. Cardiac Valvular calcificatio as amarkdr of atherosclerosis and arterial calcification in end- stage renal disease [J]. Arch Intern Med,2005,165:327 - 332.
  • 2Boon A,Cherex E, Lodder J, et al. Cardiac valve calcification Characteristics of patients with calcification of the mitrral annuus or aortic valve[J]. Heart,1997,78:472- 474.
  • 3Raine AEG. Acquired aortic stenosis in dialysis patients[J].Nephron,1994,68:159- 168.
  • 4Guerin AP, London GM, Marchais SJ, et al. Arterial stiffening and vascular calcifications in end - stage renal disease [J]. Nephrol Dial Transplant ,2000,15 : 1014 - 1021.
  • 5戎殳,叶朝阳,牛晓萍,高文武,4梅长林.血液透析患者心脏瓣膜钙化及其危险因素[J].中华肾脏病杂志,2004,20(5):364-366. 被引量:39
  • 6Pawel Strozeeki, Grazyna Odrowaz - Sypniewska, Jaeek Manitius. Cadiae Valve calcifications and left ventrieular hypertro- phy in hemodialysis patients[J]. Renal Failurre, 2005,27 : 733 - 738.
  • 7Margarita R, Sagrario G, Alejandro J ,et al. Heart valve calcification and calcium phosphorus product in hemodialysis patients:Analysis of optimum values for its prevention[J]. Kidney International,2003,163, Suppl85,115 - 118.
  • 8Faissal T, Meryern B, Mohamed Z, et al. Heart valve calcification in patients with end - stage renal disease: Analysis for risk faetors[J]. Nephrology, 2006,11 : 494 - 496.
  • 9Dejan P, Radmila O, Biljana S. Risk factors for aortic valve calcification in pationts on regular hemodialysis[J]. The internaional Journal of Artificial Organs, 2009,32 (3) : 173 - 179.

二级参考文献12

  • 1Stenvinkel P, Heimburger O, Paultre F, et al. Strong association between malnutrition, inflammation and atherosclerosis in chronic renal failure. Kidney Int, 1999, 55: 1899-1911.
  • 2Wong M, Tei C, Shah PM. Sensitivity and specificity of two-dimensional echocardiography in the detection of valvular calcification. Chest, 1983, 84: 423-427.
  • 3Ribeiro S, Ramos A, Brando A, et al. Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism.Nephrol Dial Transplant, 1998, 13: 2037-2040.
  • 4London GM, Pannier B, Marchais F, et al. Calcification of aortic valve in the dialyzed patient. J Am Soc Nephrol, 2000, 11:778-783.
  • 5Zoccali C, Benedetto FA, Mallamaci F, et al. Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed investigators. Cardiovascular risk extended evaluation in dialysis patients. J Hypertens, 2000, 18: 1207-1213.
  • 6Yeun JY, Levine RA, Mantadilok V, et al. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis, 2000, 35: 469-476.
  • 7Adler Y, Vaturi M, Fink N, et al. Association between mitral annulus calcification and aortic atheroma: a prospective transesophageal echocardiographic study. Atherosclerosis, 2000,152:451-456.
  • 8Shahi CN, Ghaisas NK, Goggins M, et al. Elevated serum levels of circulating soluble adhesion molecules in patients with nonrheumatic aortic stenosis. Am J Cardiol, 1997, 79: 980-982.
  • 9Stenvinkel P, Lindholm B, Heimburger M, et al. Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation and cardiovascular disease. Nephrol Dial Transplant, 2000, 15:1624-1630.
  • 10Tintut Y, Patel J, Parhami F, et al. Tumor necrosis factor-αpromotes in vitro calcification of vascular cells via the cAMP pathway. Circulation, 2000, 102: 2636-2642.

共引文献38

同被引文献19

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部